O'Reilly Fiona, O'Connell David, O'Carroll Austin, Whitford David L, Long Jean
Independent Research Consultant,Donabate,Co Dublin,Ireland.
North City Dublin GP TrainingScheme,Eccles St,Dublin 7.
Ir J Psychol Med. 2011 Sep;28(3):129-133. doi: 10.1017/S079096670001209X.
This study assessed patients' views of a methadone programme in a Dublin general practice including the degree to which the patients were 'involved in decisions about their treatment'.
All patients receiving methadone were asked to participate. A face to face questionnaire, with open and closed questions, was administered. Interviews lasted approximately 30 minutes. Quantitative data were analysed using descriptive statistics and qualitative data were analysed using a thematic approach.
Forty one (87%) of the 47 patients attending the general practice methadone service were interviewed. Of the 39 patients who had used heroin on admission, 69% had stopped and 31% reduced heroin use since starting methadone treatment. A total of 71% reported that the doctor either always involved (59%) or sometimes involved (12%) them in decisions about their treatment. Involvement was interpreted as 'being listened to' or 'having a say' in deciding methadone dose. Surprisingly those who reported that they were not involved in treatment decisions were more likely to have stopped heroin use (10/11). A significant majority of patients (81%) expressed the desire to stop taking methadone.
Most patients receiving methadone in general practice were listened to and had a say in deciding their methadone dose but did not have an opportunity to engage in more structured or contractual forms of involvement in treatment such as written care plans. In line with a patient centred approach, treatment providers should set their sights beyond the safe delivery of methadone, to provide a service which is centred on patient goals, expectations and choice.
本研究评估了都柏林一家普通诊所中患者对美沙酮项目的看法,包括患者“参与治疗决策”的程度。
邀请所有接受美沙酮治疗的患者参与。采用了一份包含开放式和封闭式问题的面对面调查问卷。访谈持续约30分钟。定量数据采用描述性统计进行分析,定性数据采用主题分析法进行分析。
在该普通诊所美沙酮服务中心就诊的47名患者中,41名(87%)接受了访谈。在入院时使用海洛因的39名患者中,69%自开始美沙酮治疗后已停止使用海洛因,31%减少了海洛因使用量。共有71%的患者报告称医生要么总是让他们参与(59%),要么有时让他们参与(12%)治疗决策。参与被理解为在决定美沙酮剂量时有“被倾听”或“有发言权”。令人惊讶的是,那些报告未参与治疗决策的患者更有可能已停止使用海洛因(10/11)。绝大多数患者(81%)表示希望停止服用美沙酮。
在普通诊所接受美沙酮治疗的大多数患者在决定美沙酮剂量时被倾听且有发言权,但没有机会参与更结构化或契约化的治疗参与形式,如书面护理计划。按照以患者为中心的方法,治疗提供者应将目光超越美沙酮的安全给药,提供以患者目标、期望和选择为中心的服务。